MARLBOROUGH, Mass.–(BUSINESS WIRE)–#earnings–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2020 on Wednesday, January 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialing 800-458-4121 (in the United States and Canada) or +1 323-794-2093 (for international callers) and referencing access code 7777146. Participants should dial in 5-10 minutes before the call begins. A replay will be available approximately two hours after the call ends through Friday, February 21, 2020. The replay numbers are 888-203-1112 (U.S.) or +1 719-457-0820 (international), access code 7777146, PIN 2745.
Hologic will provide a live webcast of the call on the Company’s website at www.investors.hologic.com.
The call will be archived there for 30 days.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
SOURCE: Hologic, Inc.
Contacts
Paula Izidoro
Senior Investor Relations Specialist
(858) 410-8904
paula.izidoro@hologic.com
TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…
List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…
Fuller will help drive the growth and innovation of strategic communications firmCARLSBAD, Calif.--(BUSINESS WIRE)--#AppointmentNews--Ford Hutman…
Microsoft Azure customers worldwide can now purchase Lightbeam’s care orchestration technology suite directly from the…
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and…
PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a…
